Celestial Biolabs Ltd.
BSE: 532871 | Sector: Health care |
NSE: CELESTIAL | ISIN Code: INE221I01017 |
BSE 00:00 | 11 Mar | Celestial Biolabs Ltd |
NSE 05:30 | 01 Jan | Celestial Biolabs Ltd |
OPEN | 2.02 |
PREVIOUS CLOSE | 2.02 |
VOLUME | 124 |
52-Week high | 2.02 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 5 |
Buy Price | 2.01 |
Buy Qty | 450.00 |
Sell Price | 2.02 |
Sell Qty | 1876.00 |
Celestial Biolabs Ltd. (CELESTIAL) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 961.25 | 230,632.71 | 15,585.98 | -99.99 | 30,678.37 |
Divi's Lab. | 2,798.95 | 74,298.13 | 8,879.82 | 2,948.54 | 11,718.06 |
Dr Reddy's Labs | 4,441.80 | 73,964.86 | 14,405.20 | 1,623.20 | 20,636.20 |
Cipla | 867.25 | 70,000.08 | 13,091.79 | 2,957.93 | 22,671.86 |
Apollo Hospitals | 4,305.45 | 61,903.76 | 6,098.30 | 665.20 | 8,868.60 |
Torrent Pharma. | 1,522.10 | 51,513.95 | 6,742.32 | 991.45 | 9,910.76 |
Zydus Lifesci. | 475.85 | 48,165.54 | 7,981.90 | 857.90 | 16,096.50 |
Max Healthcare | 468.10 | 45,448.76 | 1,800.06 | 331.13 | 6,780.23 |
Abbott India | 21,304.00 | 45,271.00 | 4,919.27 | 798.70 | 3,063.88 |
Alkem Lab | 3,108.65 | 37,163.91 | 8,829.81 | 1,541.25 | 11,301.35 |
Lupin | 646.20 | 29,402.10 | 11,771.67 | -188.70 | 19,439.28 |
Aurobindo Pharma | 474.25 | 27,786.31 | 11,287.14 | 1,454.71 | 19,017.26 |
Biocon | 201.80 | 24,228.11 | 1,738.20 | 86.10 | 8,279.00 |
Syngene Intl. | 575.75 | 23,112.33 | 2,601.40 | 393.80 | 4,609.20 |
Glaxosmi. Pharma | 1,281.75 | 21,714.13 | 3,217.51 | 1,690.53 | 2,948.24 |
Ipca Labs. | 780.85 | 19,810.17 | 5,399.36 | 870.94 | 6,342.72 |
Fortis Health. | 260.45 | 19,662.93 | 895.63 | -13.25 | 10,080.65 |
Gland Pharma | 1,163.80 | 19,167.79 | 4,400.71 | 1,212.16 | 7,164.70 |
Laurus Labs | 302.40 | 16,288.78 | 4,707.04 | 750.09 | 5,178.13 |
Narayana Hrudaya | 795.30 | 16,252.75 | 2,411.99 | 133.60 | 1,814.70 |
Quick Links for Celestial Biolabs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices